The Telangana IT Minister KT Rama Rao has started the construction of a new pharmaceutical-glass-tubing facility in Mahabubnagar, Telangana, India. The SGD Corning Technologies Private Limited facility is expected to cost around INR 500 crores and will play a significant role in increasing the primary packaging capabilities of the industry to support increased vaccine and critical drug production from Telangana. The SGD-Corning partnership is a welcome step forward as we move toward growing our ecosystem to achieve India’s goal of a $250B ecosystem by 2030.
SGD Pharma CEO, Olivier Rousseau, said that the partnership with Corning will expand their portfolio of high-quality tubular glass packaging and improve drug filling quality and performance capabilities by transitioning to Corning’s coated vial technology. Corning is advancing pharmaceutical glass technology to help their customers address their most pressing challenges globally and locally, said Ron Verkleeren, senior vice president and general manager of Corning’s Life Sciences Market Access Platform.
The manufacturing of Velocity Vials at SGD’s facility in Vemula, India, is expected to begin in the first quarter of 2024, while pharmaceutical tubing production is expected to start in 2025. Corning is a world leader in materials science and applies its unparalleled expertise in glass science, ceramic science, and optical physics to develop category-defining products that transform industries and enhance people’s lives. SGD Pharma is a global producer of molded and tubular glass for the pharmaceutical primary packaging industry.
